Advertisement
19 in 20 will not have an allergic reaction
An alternative to surgery when other therapies fail
New technology creates patient-specific silicone stent
How we eliminated this common but unnecessary practice
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Most patients get relief, but more than half are affected by tachyphylaxis or dependence
Long-term safety and efficacy assessed
EBUS-TBNA found safe and effective
An interview with Daniel Culver, DO
An important biomarker in left heart failure
Younger patients respond better to endothelin receptor blockers
Advertisement
Advertisement